May 1, 2025

Inversion Space Unveils Spacecraft and Wins $70M STRATFI

Kajetan A. Uhlig

Inversion Space unveiled its spacecraft and secured a $70M STRATFI contract from the U.S. military for rapid global delivery from orbit.

Inversion Space Secures Major Military Contract

Inversion Space has unveiled its spacecraft and secured a $70 million STRATFI contract from the U.S. military for rapid global delivery from orbit. The dual milestones mark the company's transition from concept to validated defense technology provider.

Rapid Global Delivery from Orbit

Inversion Space is building re-entry capsules capable of delivering payloads anywhere on Earth within hours, launched from orbital positions. The military application is immediate: the ability to rapidly resupply forward-deployed forces, deliver critical medical supplies, or deploy equipment to any location on the planet without relying on contested airspace or vulnerable logistics chains. The concept eliminates geographic constraints on military logistics.

The $70M STRATFI Validation

STRATFI (Strategic Funding Increase) is a Department of Defense program that provides significant funding to companies developing technologies with transformative military potential. A $70M award places Inversion Space among the most well-funded defense technology startups and signals strong government conviction that orbital logistics will become a critical military capability.

Playing field

Space

Entering its infrastructure build phase as commercial startups build the communications, compute, energy, and logistics layer of the trillion-dollar space economy.

Logistics

Digitizing the physical economy as cloud-native platforms replace manual processes in an industry that moves $12 trillion in goods annually.

Continue reading

Hypersonica

Hypersonica Raises EUR23M and Achieves Mach 6 Test

February 10, 2026

Fundamental Technologies

Fundamental Technologies Raises $225M Series A at $1.4B

February 5, 2026

ElevenLabs

ElevenLabs Raises $500M Series D at $11B Valuation

February 4, 2026

UiPath Acquires WorkFusion: A Portfolio Milestone

February 1, 2026

By choosing to build a company, you acknowledge and accept the potential risks associated with this decision. These may include, but are not limited to: an unhealthy obsession with fundraising, the constant sensation of being simultaneously ahead and hopelessly behind, and the inability to have a normal conversation without referencing burn multiples, CAC ratios, or other KPIs. Founders may experience chronic sleep deprivation, imposter syndrome, and an inexplicable desire to read term sheets at inappropriate moments. Side effects may also include assembling a team of brilliant misfits, firing some of them, rehiring others, and wondering if you should have just opened a coffee shop instead. In rare cases, sustained effort and market timing may result in a successful exit, though this often leads to immediate relapse into founding another startup. By continuing this journey, you waive all rights to predictable weekends, stable income, and work-life balance. But hey, no one forced you. If symptoms persist, congratulations, you’re a real founder.